Cargando…

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort

BACKGROUND: Forced expiratory volume in one second (FEV(1)) characterizes the pathophysiology of COPD and different trajectories of FEV(1) decline have been observed in patients with COPD (e.g. gradual or episodic). There is limited information about the development of patient-reported health-relate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lutter, Johanna I., Jörres, Rudolf A., Kahnert, Kathrin, Schwarzkopf, Larissa, Studnicka, Michael, Karrasch, Stefan, Schulz, Holger, Vogelmeier, Claus F., Holle, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257512/ https://www.ncbi.nlm.nih.gov/pubmed/32471493 http://dx.doi.org/10.1186/s12890-020-1147-5

Ejemplares similares

Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
por: Byng, Danalyn, et al.
Publicado: (2019)

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
por: Wacker, Margarethe E, et al.
Publicado: (2017)

Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
por: Lutter, Johanna I, et al.
Publicado: (2020)

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
por: Lutter, Johanna I, et al.
Publicado: (2021)

Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET
por: Fischer, Carolina, et al.
Publicado: (2022)

Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
por: Königsdorfer, Norbert, et al.
Publicado: (2019)

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2019)

Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2020)

Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
por: Kellerer, Christina, et al.
Publicado: (2021)

The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET
por: Kahnert, K., et al.
Publicado: (2020)

Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2023)

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2022)

Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
por: Kahnert, Kathrin, et al.
Publicado: (2022)

Heterogeneous pattern of differences in respiratory parameters between elderly with either good or poor FEV(1)
por: Karrasch, Stefan, et al.
Publicado: (2018)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
por: Karl, Florian M., et al.
Publicado: (2017)

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET
por: Trudzinski, F. C., et al.
Publicado: (2020)

Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET
por: Trudzinski, Franziska C., et al.
Publicado: (2022)

Influence of body mass on predicted values of static hyperinflation in COPD
por: Alter, Peter, et al.
Publicado: (2018)

Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data
por: Stöber, Alisa, et al.
Publicado: (2021)

Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
por: Kahnert, Kathrin, et al.
Publicado: (2022)

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
por: Kahnert, Kathrin, et al.
Publicado: (2018)

Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD
por: Alter, Peter, et al.
Publicado: (2019)

Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
por: Trudzinski, Franziska C., et al.
Publicado: (2021)

Cardiovascular predictors of mortality and exacerbations in patients with COPD
por: Alter, Peter, et al.
Publicado: (2022)

Treatment response in COPD: does FEV(1) say it all? A post hoc analysis of the CRYSTAL study
por: Kostikas, Konstantinos, et al.
Publicado: (2019)

Reference Values of Impulse Oscillometric Lung Function Indices in Adults of Advanced Age
por: Schulz, Holger, et al.
Publicado: (2013)

Health-related quality of life and chronic obstructive pulmonary disease in early stages – longitudinal results from the population-based KORA cohort in a working age population
por: Wacker, Margarethe E, et al.
Publicado: (2014)

A claims data-based comparison of comorbidity in individuals with and without dementia
por: Bauer, Kathrin, et al.
Publicado: (2014)

Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation
por: Winkler, Anna, et al.
Publicado: (2018)

Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1)
por: Lange, Peter, et al.
Publicado: (2016)

IgE is associated with exacerbations and lung function decline in COPD
por: Lommatzsch, Marek, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_unhaopselo77rd1vjmj6gmq3bp